GOLDMAN SACHS GROUP INC - VITAE PHARMACEUTICALS INC ownership

VITAE PHARMACEUTICALS INC's ticker is VTAE and the CUSIP is 92847N103. A total of 98 filers reported holding VITAE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VITAE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$1,688,000
+165.4%
80,701
+36.9%
0.00%
Q2 2016$636,000
+93.9%
58,950
+19.2%
0.00%
Q1 2016$328,000
+10.8%
49,444
+83.9%
0.00%
Q3 2015$296,000
-84.4%
26,881
-83.4%
0.00%
-100.0%
Q1 2015$1,900,000
+261.9%
162,261
+414.1%
0.00%
Q4 2014$525,00031,5610.00%
Other shareholders

There were no reported owners of VITAE PHARMACEUTICALS INC in Q3 2016.

NameSharesValueWeighting ↓
View complete list of VITAE PHARMACEUTICALS INC shareholders